BIOMAT Database Logo BIOMAT Database Logo

Guidance on medical eligibility criteria for contraceptive use: identification of research gaps. 2010

Suzanne G Folger, and Kathryn M Curtis, and Naomi K Tepper, and Mary E Gaffield, and Polly A Marchbanks
Centers for Disease Control and Prevention, Atlanta, GA 30341, USA. sxg1@cdc.gov

UI MeSH Term Description Entries
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D001942 Breast Feeding The nursing of an infant at the breast. Breast Fed,Breastfed,Milk Sharing,Wet Nursing,Breast Feeding, Exclusive,Breastfeeding,Breastfeeding, Exclusive,Exclusive Breast Feeding,Exclusive Breastfeeding,Sharing, Milk
D002487 Centers for Disease Control and Prevention, U.S. An agency of the UNITED STATES PUBLIC HEALTH SERVICE that conducts and supports programs for the prevention and control of disease and provides consultation and assistance to health departments and other countries. United States Centers for Disease Control and Prevention,CDC,CDCP,Center for Disease Control,Center for Disease Control and Prevention,Centers for Disease Control,Centers for Disease Control (U.S.),Centers for Disease Control and Prevention,Centers for Disease Control and Prevention (U.S.),Centers for Disease Control, U.S.,United States Centers for Disease Control
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003267 Contraception Prevention of CONCEPTION by blocking fertility temporarily, or permanently (STERILIZATION, REPRODUCTIVE). Common means of reversible contraception include NATURAL FAMILY PLANNING METHODS; CONTRACEPTIVE AGENTS; or CONTRACEPTIVE DEVICES. Birth Control,Contraceptive Methods,Female Contraception,Fertility Control,Inhibition of Fertilization,Male Contraception,Contraception, Female,Contraception, Male,Contraceptions, Female,Contraceptions, Male,Contraceptive Method,Female Contraceptions,Fertilization Inhibition,Male Contraceptions
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Suzanne G Folger, and Kathryn M Curtis, and Naomi K Tepper, and Mary E Gaffield, and Polly A Marchbanks
Medical-eligibility criteria for contraceptive use.
May 2001, Lancet (London, England),
Suzanne G Folger, and Kathryn M Curtis, and Naomi K Tepper, and Mary E Gaffield, and Polly A Marchbanks
The WHO's medical eligibility criteria for contraceptive use: 20 years of global guidance.
December 2015, Current opinion in obstetrics & gynecology,
Suzanne G Folger, and Kathryn M Curtis, and Naomi K Tepper, and Mary E Gaffield, and Polly A Marchbanks
Research gaps identified during the 2014 update of the WHO medical eligibility criteria for contraceptive use and selected practice recommendations for contraceptive use.
September 2016, Contraception,
Suzanne G Folger, and Kathryn M Curtis, and Naomi K Tepper, and Mary E Gaffield, and Polly A Marchbanks
U.S. medical eligibility criteria for contraceptive use, 2010.
June 2011, Journal of women's health (2002),
Suzanne G Folger, and Kathryn M Curtis, and Naomi K Tepper, and Mary E Gaffield, and Polly A Marchbanks
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016.
July 2016, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports,
Suzanne G Folger, and Kathryn M Curtis, and Naomi K Tepper, and Mary E Gaffield, and Polly A Marchbanks
U S. Medical Eligibility Criteria for Contraceptive Use, 2010.
June 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports,
Suzanne G Folger, and Kathryn M Curtis, and Naomi K Tepper, and Mary E Gaffield, and Polly A Marchbanks
Methodological quality of WHO medical eligibility criteria for contraceptive use.
July 2002, Contraception,
Suzanne G Folger, and Kathryn M Curtis, and Naomi K Tepper, and Mary E Gaffield, and Polly A Marchbanks
Adolescents and Contraception: The Updated US Medical Eligibility Criteria for Contraceptive Use.
April 2017, Journal of pediatric and adolescent gynecology,
Suzanne G Folger, and Kathryn M Curtis, and Naomi K Tepper, and Mary E Gaffield, and Polly A Marchbanks
Putting risk into perspective: the US medical eligibility criteria for contraceptive use.
June 2011, Reviews in endocrine & metabolic disorders,
Suzanne G Folger, and Kathryn M Curtis, and Naomi K Tepper, and Mary E Gaffield, and Polly A Marchbanks
United States medical eligibility criteria for contraceptive use 2010: a review of changes.
January 2011, Journal of midwifery & women's health,
Copied contents to your clipboard!